ReviewEmerging microbes & infections2012
Emerging virus diseases: can we ever expect the unexpected?
Review in Emerging microbes & infections, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 208 citations in OpenAlex.
- Article
- Antiviral and anti-inflammatory effects of Tabamide A derivative, TA25, against human rhinovirus and multiple zoonotic viruses in vitro and in silico.Scientific reports · 2026Article
- Process mapping the One Health response to a rabies outbreak in the Philippines.BMJ global health · 2026Article
- Breaking barriers: Respiratory viral strategies targeting the host's nuclear pore complex and nuclear transport pathways.Molecular biology of the cell · 2026Review
- Climate Change and the Rise of Emerging and Re-Emerging Infectious Diseases in Africa: A Literature Review.International journal of environmental research and public health · 2025Review
- Review
- Ethnobotanical study of traditional medicinal plants used to treat human ailments in West Shewa community, Oromia, Ethiopia.Frontiers in pharmacology · 2024Article
- Bibliometric Analysis of Human Metapneumovirus Studies.Infectious diseases & clinical microbiology · 2023Article
- Phenotypic Characterization of Encephalitis in the BRAINS of Badgers Naturally Infected with Canine Distemper Virus.Animals : an open access journal from MDPI · 2023Article
- Insights on monkeypox disease and its recent outbreak with evidence of nonsynonymous missense mutation.Future science OA · 2023Review
- Canine Distemper Virus Infection in the Free-Living Wild Canines, the Red Fox (Pathogens (Basel, Switzerland) · 2023Article
- HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitorActa pharmaceutica Sinica. B · 2023Article
- Effect of Transmission and Vaccination on Time to Dominance of Emerging Viral Strains: A Simulation-Based Study.Microorganisms · 2023Article
- Investigation of antiviral substances in Covid 19 by Molecular Docking: In Silico Study.African health sciences · 2023Article
- Chikungunya Virus: Priority Pathogen or Passing Trend?Vaccines · 2023Review
- Spatial and temporal distribution of emerging airborne viral infectious diseases outbreaks on a global scale.Zeitschrift fur Gesundheitswissenschaften = Journal of public health · 2023Article
- Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model.Journal, genetic engineering & biotechnology · 2023Article
- Medicinal Plants Used for the Management of Hepatitis Over the Past 15 Years in Ethiopia: A Systematic Review.Hepatic medicine : evidence and research · 2023Review
- Multiplexed rapid antigen tests developed using multicolored nanoparticles and cross-reactive antibody pairs: Implications for pandemic preparedness.Nano today · 2022Article
- Global Research Trends on Monkeypox Virus: A Bibliometric and Visualized Study.Tropical medicine and infectious disease · 2022Review
34 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging virus diseases are a major threat to human and veterinary public health. With new examples occurring approximately one each year, the majority are viruses originating from an animal host. Of the many factors responsible, changes to local ecosystems that perturb the balance between pathogen and principal host species is one of the major drivers, together with increasing urbanization of mankind and changes in human behavior. Many emerging viruses have RNA genomes and as such are capable of rapid mutation and selection of new variants in the face of environmental changes in host numbers and available target species. This review summarizes recent work on aspects of virus emergence and the current understanding of the molecular and immunological basis whereby viruses may cross between species and become established in new ecological niches. Emergence is hard to predict, although mathematical modeling and spatial epidemiology have done much to improve the prediction of where emergence may occur. However, much needs to be done to ensure adequate surveillance is maintained of animal species known to present the greatest risk thus increasing general alertness among physicians, veterinarians and those responsible for formulating public health policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.